Global Vaccine Contract Manufacturing Market Poised for Growth, Expected to Reach $5.32 Billion by 2028
Vaccine Contract Manufacturing Global Market Report 2024 : Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Vaccine Contract Manufacturing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
LONDON, GREATER LONDON, UK, July 4, 2024 /EINPresswire.com/ -- The global vaccine contract manufacturing market has shown robust growth, expanding from $3.3 billion in 2023 to $3.62 billion in 2024, marking a compound annual growth rate (CAGR) of 9.9%. This growth is attributed to various factors such as traditional vaccine manufacturing limitations, heightened global disease outbreaks, supportive regulatory frameworks for contract manufacturing, increasing complexity in vaccine production, and a surge in research and development activities.
Rising Demand for Pandemic Preparedness and Outsourcing Drives Market Growth
The market is expected to continue its rapid expansion, reaching $5.32 billion by 2028 with a CAGR of 10.1%. This forecasted growth is driven by an increasing emphasis on pandemic preparedness, rising outsourcing trends in pharmaceutical manufacturing, expanding biopharmaceutical companies, accelerated timelines for vaccine development, and global initiatives aimed at enhancing vaccine accessibility.
Explore the global vaccine contract manufacturing market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=12216&type=smp
Major Players and Market Trends
Key players such as Pfizer Inc., Johnson & Johnson, and Sanofi are actively involved in enhancing their market presence through strategic initiatives. Companies are focusing on integrating single-use technologies in manufacturing, advancing personalized medicine approaches to vaccine development, developing mRNA and viral vector vaccines, adopting continuous manufacturing processes, and expanding fill-finish services.
Segments
• Service Type: Fill-Finish, Bulk Product
• Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
• Process: Downstream, Upstream
• Scale Of Operation: Preclinical, Clinical, Commercial
• End-Use: Human Use, Veterinary
Geographical Insights: Asia-Pacific Leading Growth
North America emerged as the largest region in the vaccine contract manufacturing market in 2023. However, Asia-Pacific is projected to be the fastest-growing region during the forecast period. Detailed insights into regional dynamics and growth opportunities are available in the comprehensive report.
Access the complete report for an in-depth analysis of the global vaccine contract manufacturing market: https://www.thebusinessresearchcompany.com/report/vaccine-contract-manufacturing-global-market-report
Vaccine Contract Manufacturing Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Vaccine Contract Manufacturing Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on vaccine contract manufacturing market size, vaccine contract manufacturing market drivers and trends, vaccine contract manufacturing market major players, competitors' revenues, market positioning, and market growth across geographies. The vaccine contract manufacturing market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Pediatric Vaccine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report
About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
